Raymond James Financial Inc Acadia Pharmaceuticals Inc Transaction History
Raymond James Financial Inc
- $258 Billion
- Q1 2025
A detailed history of Raymond James Financial Inc transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Raymond James Financial Inc holds 28,283 shares of ACAD stock, worth $630,710. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,283
Previous 36,161
21.79%
Holding current value
$630,710
Previous $663,000
29.26%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ACAD
# of Institutions
351Shares Held
165MCall Options Held
1.77MPut Options Held
307K-
Baker Bros. Advisors LP New York, NY42.9MShares$956 Million8.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.2MShares$339 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$269 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY8.54MShares$190 Million2.32% of portfolio
-
State Street Corp Boston, MA6.99MShares$156 Million0.0% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $3.61B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...